[在新诊断为扩散型大B细胞淋巴瘤的患者中,对外周血液B细胞计数与临床特征和预后的相关性分析]
Tian Lu1,2, Hao Mi1,2, Dan-Dan Zhao2
1College of Clinical Medicine, Jining Medical University, Jining 272013, Shandong Province, China.
Zhongguo shi yan xue ye xue za zhi
|April 25, 2024
概括
新诊断的扩散性大B细胞淋巴瘤 (DLBCL) 患者的周围血液B细胞数量下降与高风险特征和更差的预后相关. 这一发现表明B细胞计数可能会影响免疫化学疗法的疗效和患者的治疗结果.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
更多相关视频
10:18From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
Published on: October 19, 2014
13.7K
14:45Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
Published on: September 16, 2012
15.0K
